Last Posted: Jan 16, 2020
- A new comprehensive colorectal cancer risk prediction model incorporating family history, personal characteristics, and environmental factors.
Zheng Yingye et al. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2020 Jan - Associations of Pathogenic Variants in MLH1, MSH2, and MSH6 With Risk of Colorectal Adenomas and Tumors and With Somatic Mutations in Patients With Lynch Syndrome.
Engel Christoph et al. Gastroenterology 2020 Jan - Colorectal Cancer Family History Ascertainment in the Age of Genomic Medicine: More Important Than Ever!
Weber Thomas et al. Diseases of the colon and rectum 2020 Feb 63(2) 125-128 - Implementing anti-epidermal growth factor receptor (EGFR) therapy in metastatic colorectal cancer: challenges and future perspectives.
Martinelli E et al. Annals of oncology : official journal of the European Society for Medical Oncology 2020 Jan 31(1) 30-40 - Natera Launches Study for Colorectal Cancer Cell-Free DNA Blood Test,
Genome Web, January 9, 2020 - Prognostic value of a hypoxia-related microRNA signature in patients with colorectal cancer.
Yang Yongmei et al. Aging 2020 Jan 12 - Improving cancer screening programs
M Kalager et al, Science, January 10, 2020 - Hybrid Capture-Based Genomic Profiling of Circulating Tumor DNA from Patients with Advanced Cancers of the Gastrointestinal Tract or Anus.
Schrock Alexa B et al. Clinical cancer research : an official journal of the American Association for Cancer Research 2018 24(8) 1881-1890 - The Expression Profile and Prognostic Significance of Metallothionein Genes in Colorectal Cancer.
Hung Kuo-Chen et al. International journal of molecular sciences 2019 Aug 20(16) - FOLFOX treatment response prediction in metastatic or recurrent colorectal cancer patients via machine learning algorithms.
Lu Wei et al. Cancer medicine 2020 Jan
.png)
No hay comentarios:
Publicar un comentario